The mean of analysts' price targets for Mind Medicine MindMed (MNMD) points to a 237.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The consensus price target hints at a 34.1% upside potential for Ooma (OOMA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

VirTra makes a strong case for investment in the electronics military industry, given its growth prospects, stable backlog and wide market reach.

Skillsoft (SKIL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Canopy Growth Corporation (NASDAQ:CGC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/canopy-growth-corporation-lawsuit-submission-form?prid=151269&wire=1&utm_campaign=22 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your DoubleVerify Holdings, Inc. (NYSE:DV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/doubleverify-holdings-inc-lawsuit-submission-form-2?prid=151268&wire=1&utm_campaign=22 or contact Joseph E. Levi, Esq.

BOCA RATON, FL, June 02, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the “Company”) the first US-listed public company with a treasury strategy built to accumulate and compound Solana (“SOL”), today announced that Head of Investor Relations Dan Kang will be speaking at Maxim Group's 2025 Virtual Tech Conference on Thursday, June 5, 2025, at 10:00 a.m. Eastern Time.

BOSTON, June 2, 2025 /PRNewswire/ -- This press release concerns Capri Holdings Ltd (NYSE: CPRI) and valuable claims that people or entities that SOLD Capri stock may have against Capri. People or Entities That Sold Capri Holdings Ltd (CPRI) Stock Have Valuable Claims Against Capri If you sold any shares of Capri common stock during the period May 28, 2023, through July 1, 2023, or during the period July 30, 2023, through August 9, 2023, you may have valuable claims against Capri for Capri's violations of the federal securities laws and you may be able to recover significant money damages …

Strategic Licensing Rights Strengthen Harte Hanks' Leadership in Compliant, High-Precision Healthcare Marketing CHELMSFORD, MA / ACCESS Newswire / June 2, 2025 / Harte Hanks (NASDAQ:HHS), a global leader in customer experience and data-driven marketing, today announced that it has obtained exclusive rights to license ADS Data Direct's (ADS) industry-leading Medical Ailment Database, with limited client exceptions. This transformative undertaking positions Harte Hanks as the controller of one of the most comprehensive, HIPAA-compliant health data assets available in the market, delivering unmatched value to healthcare marketers.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Rocket Pharmaceuticals, Inc. ("Rocket Pharmaceuticals, Inc.") (NASDAQ:RCKT) concerning possible violations of federal securities laws. Rocket issued a press release on May 27, 2025, "announc[ing] an update related to RP-A501, its investigational gene therapy for Danon disease.

TAMPA, Fla.--(BUSINESS WIRE)--Fifth Third Bank, National Association, (Nasdaq: FITB) has announced Scott Daigle as North Florida region president. Daigle succeeds Cary Putrino, who has transitioned into a new role as region chairman in North Florida. Putrino will focus on business development, special projects and brand ambassadorship. “Cary has exemplified what strong regional leadership looks like—building trusted relationships, fostering deep community engagement and consistently prioritizin.

PRINCETON, N.J.--(BUSINESS WIRE)--UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the presentation of the uTRACT Registry study design at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL. The uTRACT Registry is a single-arm, multicenter, prospective and retrospective study evaluating the real-world use of JELMYTO® (mitomycin) for pyelo.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=151267&wire=1&utm_campaign=28 or contact Joseph E. Levi, Esq.

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Civitas Resources, Inc. (“Civitas” or the “Company”) (NYSE: CIVI) and certain officers. The class action, filed in the United States District Court for the District of New Jersey, and docketed under 25-cv- 03791, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Civitas securities between February 27, 2024 and February 24, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants' violations of the federal …

"You cannot not believe in science," says Tsvetta Kaleynska. She sees biotech companies outperforming in 2025 despite a slow start to the year.

LOS ANGELES , June 2, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Avis Budget Group, Inc. ("Avis Budget" or "the Company") (NASDAQ: CAR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 16, 2024 and February 10, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before June 24, 2025.

LOS ANGELES , June 2, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of UnitedHealth Group Incorporated ("UnitedHealth" or "the Company") (NYSE: UNH) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.